The Korean Journal of Internal Medicine

Search

Close

Original Article
Korean J Med. 2007;72(3):272-280.
원저 : 췌관내 유두상 점액 종양의 임상상 및 병리학적 특징: 악성 종양 예측인자를 중심으로
윤원재, , , , , , , , ,
Clinicopathological features of intraductal papillary mucinous neoplasms of the pancreas:an emphasis on predictors of malignancy
Won Jae Yoon, Jun Kyu Lee, Joo Kyung Park, Sang Hyub Lee, Ji Kon Ryu, Yong Tae Kim, Yong Bum Yoon, Jin Young Jang, Sun Whe Kim, Woo Ho Kim
고려대학교 의과대학 내과학교실


Abstract
Background : Intraductal papillary mucinous neoplasm of the pancrea (IPMN) is a newly recognized category of pancreatic exocrine tumors with a favorable prognosis. We conducted this study to evaluate clinicopathological features of IPMNs and to evaluate clinical factors associated with malignant IPMNs.
Methods
: We retrospectively evaluated 91 patients (55 males, mean age 61.6 years) who were diagnosed with IPMNs with histological confirmation from 1993 to 2004.
Results
: Fifty-eight cases were incidentally found, whereas 33 cases were symptomatic. Pathology revealed adenoma in 19 cases, IPMN with moderate dysplasia in 50 cases, noninvasive carcinoma in 8 cases, and invasive carcinoma in 14 cases. In main duct type (n=13) and combined type IPMNs (n=5), visible mucin secretion as seen on endoscopy indicated a borderline association with malignancy; a large tumor diameter (≥30 mm) was associated with malignancy. In branch duct type IPMNs (n=73), the presence of symptoms or signs, the presence of mural nodules, a large tumor diameter (≥27 mm) and a larger main pancreatic duct diameter (≥4 mm) were associated with malignancy.
Conclusions
: In IPMNs involving the main pancreatic duct, a large tumor diameter (≥30 mm) is associated with malignancy. In branch duct type IPMNs, the presence of symptoms or signs, the presence of mural nodules, a large tumor diameter (≥27 mm) and a large main pancreatic duct diameter (≥4 mm) are associated with malignancy.(Korean J Med 72:272-280, 2007) Key Words : Pancreas, Neoplasms

Keywords :Pancreas, Neoplasms
hanmi ckdpharm. AMGEN
Memo patch yungjin daewoongbio

Go to Top